Evidence map›Paper›PMID 21458983›Full record

ReviewCurrent opinion in structural biology2011

Topological variation in the evolution of new reactions in functionally diverse enzyme superfamilies.

Elaine C Meng, Patricia C Babbitt

Abstract readReview
In one paragraph

Review in Current opinion in structural biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Mechanisms of protein evolution.Protein science : a publication of the Protein Society · 2022
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. The evolution of enzyme function in the isomerases.Current opinion in structural biology · 2014
    Review
  10. Article
  11. Article
  12. Divergence and convergence in enzyme evolution.The Journal of biological chemistry · 2012
    Review
  13. Enzyme informatics.Current topics in medicinal chemistry · 2012
    Review
  14. Brain miffed by macrophage migration inhibitory factor.International journal of cell biology · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Elaine C MengDepartment of Pharmaceutical Chemistry, University of California, 600 16th Street, San Francisco, CA 94158-2517, USA.
Patricia C Babbitt

Funding

XRAY CRYSTALLOGRAPHIC STRUCTURE ANALYSIS: PROTEIN SORTINGP41RR001081 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI COHEN, BRUCE E · 1985 to 2011
$17.6M
Laying the Foundation of Genomic EnzymologyR01GM060595 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BABBITT, PATRICIA CLEMENT · 2000 to 2018
$5.4M
NCRR NIH HHS P41 RR001081NIGMS NIH HHS GM60595NIGMS NIH HHS R01 GM060595
6 · The paper itself

Abstract

In functionally diverse enzyme superfamilies (SFs), conserved structural and active site features reflect catalytic capabilities 'hard-wired' in each SF architecture. Overlaid on this foundation, evolutionary changes in active site machinery, structural topology and other aspects of structural organization and interactions support the emergence of new reactions, mechanisms, and substrate specificity. This review connects topological with functional variation in each of the haloalkanoic acid dehalogenase (HAD) and vicinal oxygen chelate fold (VOC) SFs and a set of redox-active thioredoxin (Trx)-fold SFs to illustrate a few of the varied themes nature has used to evolve new functions from a limited set of structural scaffolds.

Indexed as

Evolution, MolecularAnimalsCatalytic DomainConserved SequenceEnzymesHumansHydrolasesModels, MolecularProtein ConformationSubstrate SpecificityThioredoxins2-haloacid dehalogenaseEnzymesHydrolasesThioredoxins

Identifiers

PMID21458983
PMCPMC3551608

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.